RECOMBINANT EPHB4-HSA FUSION PROTEIN AND AZACITIDINE OR DECITABINE FOR RELAPSED OR REFRACTORY MYELODYSPLASTIC SYNDROME, CHRONIC MYELOMONOCYTIC LEUKEMIA, OR ACUTE MYELOID LEUKEMIA PATIENTS PREVIOUSLY TREATED WITH A HYPOMETHYLATING AGENT: